An AI-driven attack campaign, active from early to mid-September 2026, compromised over 27 companies and exfiltrated data from 600,000 credit cards. Utilizing open-source AI tools, the sophisticated operation executed rapid, low-cost cyber incursions, highlighting the increasing complexity of AI in cybercrime.

Verana Health launches AI-driven Agent Claire to transform life sciences R&D by integrating AI agents into core operations, enhancing development and patient therapy access. Leveraging real-world data, Claire offers transparency and clinical insights, aligning with industry protocols for seamless integration.

HR teams are leveraging AI systems like greytHR NAVOS to significantly cut down administrative times and costs, improving efficiency in payroll and employee management tasks. These AI-assisted workflows have notably increased HR operation bandwidth, with reported outcomes showing remarkable reductions in HR management costs and improved compliance in attendance tracking.

Take Time, a breakout puzzle game from Libellud/Asmodee, sold over 325,000 copies within a year of its launch, surpassing expectations. Strong European demand and strategic marketing, including a demo kit, boosted its reach and led to plans for further expansions and digital adaptations.

India is revamping its statistical system for more agile data flow across ministries and states by standardizing data definitions and formats. The Mospi utilizes AI for analytics under strict controls, while initiatives like PM Gati Shakti and One Nation, One Ration Card benefit from improved data interoperability.

Timeline Studio introduces a groundbreaking update allowing users to merge traditional and AI-generated content seamlessly in video projects. Led by Dr. Duane Varan, the platform now supports advanced features like dynamic subtitles, AI-enhanced scenes, and multilingual dubbing in over 90 languages, transforming the landscape of video production.

CAR T therapy's evolution is driven by efficient gene transfer, CD28 costimulation, and biomanufacturing, expanding into autoimmune and solid-tumor strategies. AI and advanced receptor architectures are key to future therapeutic developments, highlighted at the Tang Prize Masters Forum.

Research reveals sdRNA-D21, a fragment from small nucleolar RNA, plays a significant role in osteoarthritis progression by disrupting ER-phagy and increasing chondrocyte apoptosis. The findings suggest potential therapeutic targets, though challenges in delivery and validation persist.

UBE2N is a crucial regulator in metabolic dysfunction-associated steatohepatitis (MASH), determining cell repair or inflammatory death. Targeting UBE2N or the p62 pathway offers a promising therapeutic strategy, supported by research on liver tissues and mouse models.

Morgan Stanley is transforming its API program with CALM and FINOS CALM to enhance AI agent support while ensuring secure and compliant API deployment. This initiative reduces deployment times from years to weeks, integrating architecture and security safeguards for seamless AI tool interaction.